1-9 of 9
A Richter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Liposomal Daunorubicin and Cytarabine Versus Cladribine and High-Dose Cytarabine-Based Induction Chemotherapy in Secondary Acute Myeloid Leukemia Patients (sAML) or Acute Myeloid Leukemia with Myelodysplastic Related Changes (AML-MRC)

Ariel Denson, Ryan J. Caddell, Katherine A. Richter, Jiannong Li, Kendra Sweet, Andrew T. Kuykendall, Eric Padron, Rami S. Komrokji, Jeffrey E. Lancet, Chetasi Talati, David A. Sallman
Journal: Blood
Blood (2021) 138 (Supplement 1): 1258.
https://doi.org/10.1182/blood-2021-151303
Published: 2021
Journal Articles

Evaluation of Early Discharge after Intensive Induction Chemotherapy in Adults with Acute Myeloid Leukemia

Amanda Al-Bahou, Katherine A. Richter, Matthew Snyder, Sarah J. Rockwell, Seongseok Yun, Timothy E. Kubal
Journal: Blood
Blood (2021) 138 (Supplement 1): 4043.
https://doi.org/10.1182/blood-2021-151749
Published: 2021
Journal Articles

Evaluation of Dose-Adjusted EPOCH-R Compared with R-CHOP for the Treatment of High-Risk, Aggressive B-Cell Lymphomas: A Single-Center Experience

Sarah J. Rockwell, BS,PharmD, Katherine A. Richter, PharmD, MBA, BCOP, Ryan J. Caddell, PharmD, BCOP, Julio C. Chavez, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-140085
Published: 2020
Journal Articles

A Novel Pro-Survival Function of Cyclin-D1 Underlies Its Oncogenic Role and Potential as a Therapeutic Target In Mantle Cell Lymphoma

Elena Beltran, PhD, Vicente Fresquet, PhD, Javier Martinez-Useros, Jose A. Richter-Larrea, PhD, Ainara Sagardoy, PhD, Izaskun Sesma, Luciana L. Almada, PhD, Santiago Montes-Moreno, MD, Stefan Gesk, MD, Reiner Siebert, Prof., Dr., med., MaJose Calasanz, PhD, Felipe Prosper, MD, Miguel A. Piris, MD, Martin E. Fernandez-Zapico, MD, Jose A Martinez-Climent, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 769.
https://doi.org/10.1182/blood.V116.21.769.769
Published: 2010
Journal Articles

Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma

Jose A. Richter-Larrea, Eloy F. Robles, Vicente Fresquet, Elena Beltran, Antonio J. Rullan, Xabier Agirre, Maria José Calasanz, Carlos Panizo, Jose A. Richter, Jesus M. Hernandez, Jose Roman-Gomez, Felipe Prosper, Jose A. Martinez-Climent
Journal: Blood
Blood (2010) 116 (14): 2531–2542.
https://doi.org/10.1182/blood-2010-02-268003
Published: 2010
Includes: Supplemental data
Journal Articles

Epigenetic Silencing of BIM Mediates Chemotherapy Resistance of Patients with Burkitt Lymphoma That Can Be Overcome by Therapeutic Reactivation of BIM in Mouse and Human Lymphoma Models

Jose A. Richter, MSc, Antonio Rullan, Elena Beltran, MSc, Xabier Agirre, PhD, M.a José Calasanz, PhD, Jose Roman-Gomez, MD, Carlos Panizo, MD, Jesus M Hernandez, MD, PhD, Felipe Prosper, MD, Vicente Fresquet, PhD, Jose A. Martinez-Climent, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 607.
https://doi.org/10.1182/blood.V112.11.607.607
Published: 2008
Journal Articles

Gene Expression and Proteomic Profiling Predict Therapeutic Response to ABT-737 in Human and Mouse Models of Mantle Cell Lymphoma

Elena Beltran, MSc, Vicente Fresquet, PhD, Jose A Richter, MSc, Miguel A. Piris, MD, Reiner Siebert, MD, Jose A. Martinez-Climent, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 608.
https://doi.org/10.1182/blood.V112.11.608.608
Published: 2008
Journal Articles

Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas

Cinta Mestre-Escorihuela, Fanny Rubio-Moscardo, Jose A. Richter, Reiner Siebert, Joan Climent, Vicente Fresquet, Elena Beltran, Xabier Agirre, Isabel Marugan, Miguel Marín, Andreas Rosenwald, Kei-ji Sugimoto, Luise M. Wheat, E. Loraine Karran, Juan F. García, Lydia Sanchez, Felipe Prosper, Louis M. Staudt, Daniel Pinkel, Martin J. S. Dyer, Jose A. Martinez-Climent
Journal: Blood
Blood (2006) 109 (1): 271–280.
https://doi.org/10.1182/blood-2006-06-026500
Published: 2006
Includes: Supplemental data
Journal Articles

Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells

RM Lemoli, T Igarashi, M Knizewski, L Acaba, A Richter, A Jain, D Mitchell, J Levy, SC Gulati
Journal: Blood
Blood (1993) 81 (3): 793–800.
https://doi.org/10.1182/blood.V81.3.793.793
Published: 1993